Eptinezumab for migraine prevention in patients 50 years or older: A subgroup analysis of PROMISE-1 and PROMISE-2

Martin, VT; Tassorelli, C; Ettrup, A; Hirman, J; Cady, R

HEADACHE, 2021; 61 (): 125